CardioVascular Technologies, Inc.

About

Percutaneous Bypass, CABG, Percutaneous Valve Treatment Device, PTCA / PTA, RX, OTW, PTMR, PMR, RF Tissue Cutting, cardiovascular technologies, inc

CardioVascular Technologies, Inc. (CVT) is a biomedical device development company, specializing in the creation of cutting edge surgical and catheter-based technologies - several of our medical device patents have been licensed to existing companies, as well as to create new start up companies.

CVT also provides consulting services - We assist companies of all sizes, as well as individuals (including physicians, engineers, and entrepreneurs). Our consulting services focus on two specific areas, intellectual property and rapid prototype development. We have also designed and set up medical device production facilities (including assembly equipment) at overseas locations.

CardioVascular Technologies, Inc

Company Management and Advisors

Therapeutic, CABG, Percutaneous Valve Treatment Device, RF Tissue Cutting, Tissue Removing, Stent Graft Deployment, cardiovascular technologies, inc

Russ Houser - CEO & Chairman

Russ Houser

Carlo Pappone - M.D., PhD, F.A.C.C. - Medical Advisor

Carlo Pappone, San Raffaele University Hospital

Casey McGlynn (Partner, WSG&R - Palo Alto, Ca) - Lead Corporate Attorney

Casey McGlynn

Mission Statement

Therapeutic, CABG, Percutaneous Valve Treatment Device, RF Tissue Cutting, Tissue Removing, Stent Graft Deployment, cardiovascular technologies, inc

Our mission is to create innovative and enabling medical technologies, addressing unmet clinical needs to improve the standard of care and quality of life.

Cardiovascular Technologies, inc